Amalgamation of Nanoparticles within Drug Carriers: A Synergistic Approach or a Futile Attempt?

Author:

Pai Rohan1ORCID,Mehta Nikhil1

Affiliation:

1. Department of Pharmaceutics, Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM's NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai - 400056, India

Abstract

Abstract: In recent years, nanotechnology has gained much attention from scientists for the obtainment of significant advances in therapeutic potential. Nano-delivery systems have emerged as an effective way to improve the therapeutic properties of drugs, including solubility, stability, prolongation of half-life, as well as promoting the accumulation of drug at the target site. The nanoparticles have also been incorporated into various conventional drug delivery systems. This review study aims to introduce the amalgamation of nanoparticles into drug carriers. To overcome the limitations of single nanoparticles, such as toxicity, high instability, rapid drug release as well as limited drug loading capacity, a multi-component system is developed. Liposomes, microparticles, nanofibers, dendrimers, etc., are promising drug carriers, having some limitations that can be minimized, and the compilation of nanoparticles synergizes the properties. The amalgamated nanocarriers are used for the diagnostic purpose as well as treatment of various chronic diseases. It also increases the solubility of hydrophobic drugs. However, each system has its advantages and disadvantages based on its physicochemical properties, efficacy, and other parameters. This review details the past and present state of development for the fusion of nanoparticles within drug carriers and future research works are needed for the same.

Publisher

Bentham Science Publishers Ltd.

Subject

Biomedical Engineering,Pharmaceutical Science

Reference137 articles.

1. Siddiqui M.D.N.; Garg G.; Sharma P.K.; A Short Review on “ A Novel Approach in Oral Fast Dissolving Drug Delivery System and Their Pa-tents ” Conventional Oral Modified Release Fast Action Oral Solid. Int J Pharm Sci Rev Res 2011,5,291-303

2. Mishra D.M.K.; A Review Article on the Oral Dosage Form: Tablets. World J Pharm Res 2017,6,264-271

3. Gavhane S.A.; The Novel Drug Delivery System. Int Journal of Creative Research Thoughts 2021,9,373-385

4. Bangham A.D.; Horne R.W.; Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J Mol Biol 1964,8(5),660-IN10

5. Sainz V.; Conniot J.; Matos A.I.; Regulatory aspects on nanomedicines. Biochem Biophys Res Commun 2015,468(3),504-510

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3